These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 20739362)

  • 1. Pharmacological inhibition of TLR9 activation blocks autoantibody production in human B cells from SLE patients.
    Capolunghi F; Rosado MM; Cascioli S; Girolami E; Bordasco S; Vivarelli M; Ruggiero B; Cortis E; Insalaco A; Fantò N; Gallo G; Nucera E; Loiarro M; Sette C; De Santis R; Carsetti R; Ruggiero V
    Rheumatology (Oxford); 2010 Dec; 49(12):2281-9. PubMed ID: 20739362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of pathogenic auto-antibody production by Toll-like receptor 9 of B cells in active systemic lupus erythematosus.
    Nakano S; Morimoto S; Suzuki J; Nozawa K; Amano H; Tokano Y; Takasaki Y
    Rheumatology (Oxford); 2008 Feb; 47(2):145-9. PubMed ID: 18160420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Up-regulation of the endoplasmic reticulum transmembrane protein UNC93B in the B cells of patients with active systemic lupus erythematosus.
    Nakano S; Morimoto S; Suzuki S; Watanabe T; Amano H; Takasaki Y
    Rheumatology (Oxford); 2010 May; 49(5):876-81. PubMed ID: 20159909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased BCMA expression in lupus marks activated B cells, and BCMA receptor engagement enhances the response to TLR9 stimulation.
    Kim J; Gross JA; Dillon SR; Min JK; Elkon KB
    Autoimmunity; 2011 Mar; 44(2):69-81. PubMed ID: 21250838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expansion of toll-like receptor 9-expressing B cells in active systemic lupus erythematosus: implications for the induction and maintenance of the autoimmune process.
    Papadimitraki ED; Choulaki C; Koutala E; Bertsias G; Tsatsanis C; Gergianaki I; Raptopoulou A; Kritikos HD; Mamalaki C; Sidiropoulos P; Boumpas DT
    Arthritis Rheum; 2006 Nov; 54(11):3601-11. PubMed ID: 17075805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The expressions of Toll-like receptor 9 and T-bet in circulating B and T cells in newly diagnosed, untreated systemic lupus erythematosus and correlations with disease activity and laboratory data in a Chinese population.
    Wu O; Chen GP; Chen H; Li XP; Xu JH; Zhao SS; Sheng J; Feng JB; Cai J; Fang XH; Zhang WH; Li LH; Zhang N; Li J; Li JJ; Pan FM; Wang CZ; Ye DQ
    Immunobiology; 2009; 214(5):392-402. PubMed ID: 19362685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pivotal Advance: Inhibition of MyD88 dimerization and recruitment of IRAK1 and IRAK4 by a novel peptidomimetic compound.
    Loiarro M; Capolunghi F; Fantò N; Gallo G; Campo S; Arseni B; Carsetti R; Carminati P; De Santis R; Ruggiero V; Sette C
    J Leukoc Biol; 2007 Oct; 82(4):801-10. PubMed ID: 17548806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toll-like receptor 9-independent aggravation of glomerulonephritis in a novel model of SLE.
    Yu P; Wellmann U; Kunder S; Quintanilla-Martinez L; Jennen L; Dear N; Amann K; Bauer S; Winkler TH; Wagner H
    Int Immunol; 2006 Aug; 18(8):1211-9. PubMed ID: 16798839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TLR9 in peritoneal B-1b cells is essential for production of protective self-reactive IgM to control Th17 cells and severe autoimmunity.
    Stoehr AD; Schoen CT; Mertes MM; Eiglmeier S; Holecska V; Lorenz AK; Schommartz T; Schoen AL; Hess C; Winkler A; Wardemann H; Ehlers M
    J Immunol; 2011 Sep; 187(6):2953-65. PubMed ID: 21859955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blockade of TLR9 signaling in B cells impaired anti-dsDNA antibody production in mice induced by activated syngenic lymphocyte-derived DNA immunization.
    Chen M; Zhang W; Xu W; Zhang F; Xiong S
    Mol Immunol; 2011 Jul; 48(12-13):1532-9. PubMed ID: 21592581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TLR9/MyD88 signaling is required for class switching to pathogenic IgG2a and 2b autoantibodies in SLE.
    Ehlers M; Fukuyama H; McGaha TL; Aderem A; Ravetch JV
    J Exp Med; 2006 Mar; 203(3):553-61. PubMed ID: 16492804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production.
    Morimoto S; Nakano S; Watanabe T; Tamayama Y; Mitsuo A; Nakiri Y; Suzuki J; Nozawa K; Amano H; Tokano Y; Kobata T; Takasaki Y
    Rheumatology (Oxford); 2007 Jul; 46(7):1083-6. PubMed ID: 17500077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nucleosome-induced neutrophil activation occurs independently of TLR9 and endosomal acidification: implications for systemic lupus erythematosus.
    Lindau D; Rönnefarth V; Erbacher A; Rammensee HG; Decker P
    Eur J Immunol; 2011 Mar; 41(3):669-81. PubMed ID: 21287547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging roles of TLR7 and TLR9 in murine SLE.
    Santiago-Raber ML; Baudino L; Izui S
    J Autoimmun; 2009; 33(3-4):231-8. PubMed ID: 19846276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Active systemic lupus erythematosus is associated with a reduced cytokine production by B cells in response to TLR9 stimulation.
    Sieber J; Daridon C; Fleischer SJ; Fleischer V; Hiepe F; Alexander T; Heine G; Burmester GR; Fillatreau S; Dörner T
    Arthritis Res Ther; 2014 Nov; 16(6):477. PubMed ID: 25385499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Higher-order CpG-DNA stimulation reveals distinct activation requirements for marginal zone and follicular B cells in lupus mice.
    Brummel R; Roberts TL; Stacey KJ; Lenert P
    Eur J Immunol; 2006 Jul; 36(7):1951-62. PubMed ID: 16791898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacterial DNA motifs trigger ANCA production in ANCA-associated vasculitis in remission.
    Tadema H; Abdulahad WH; Lepse N; Stegeman CA; Kallenberg CG; Heeringa P
    Rheumatology (Oxford); 2011 Apr; 50(4):689-96. PubMed ID: 21149241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toll-like receptor expression in lupus peripheral blood mononuclear cells.
    Migita K; Miyashita T; Maeda Y; Nakamura M; Yatsuhashi H; Kimura H; Ishibashi H; Eguchi K
    J Rheumatol; 2007 Mar; 34(3):493-500. PubMed ID: 17295441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct autoantibody profiles in systemic lupus erythematosus patients are selectively associated with TLR7 and TLR9 upregulation.
    Chauhan SK; Singh VV; Rai R; Rai M; Rai G
    J Clin Immunol; 2013 Jul; 33(5):954-64. PubMed ID: 23564191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B-cell receptor for antigen modulates B-cell responses to complex TLR9 agonists and antagonists: implications for systemic lupus erythematosus.
    Goeken JA; Layer T; Fleenor S; Laccheo M; Lenert P
    Lupus; 2010 Oct; 19(11):1290-301. PubMed ID: 20605877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.